Businessfriend Makes Health Recruitment More Efficient
Recruitment in the healthcare industry is complex. HR managers and healthcare recruiters have a difficult job searching for qualified candidates for healthcare jobs. Recruiters need to help market and sell the job opportunity to healthcare professionals. They are then required to pre-qualify the candidate based on their education, credentials, and prior experience, and assist with coordinating the interview process. Usually the pre-qualification process involves reviewing many CVs and resumes and then phone interviewing the candidates who appear most qualified on paper. However, a new tool for business professionals, Businessfriend is helping healthcare recruits simplify the process and make recruitment more efficient and effective.
Healthcare Global spoke to Philip Diehl, Marketing Manager at Businessfriend about how the new social and business tool can improve recruitment in the healthcare sector >>>
HCG: How can healthcare executives use Businessfriend to organise their recruitment process?
PD:Businessfriend offers a hiring manager that is very flexible and customizable based on the recruiter's needs. Once a job is posted and users begin to apply, applications are organized automatically based on where they fall in the recruitment process. If they are brand new applicants they will be labeled and organized into an individual folder labeled “New Applicant”. The same automated organization applies as the candidate moves through the interview process. Once they are viewed they are labeled as viewed, then they move to the status “Pending Interview” once an interview is scheduled and so on. And if that is not good enough the recruiter can also use tags to create custom folders allowing for total control of the recruitment process to suit the needs of the business.
HCG: How does Businessfriend’s compatibility scoring system work and how can it help recruiters in the healthcare industry make the recruitment process more efficient?
PD:The compatibility score is based on the job posting itself. Every criteria created by the recruiter becomes part of the algorithm for the compatibility score including skills, education, location, past experience etc. When the applicant applies they are asked a few questions. Based upon their answers and the information in their profile the Job Manager will go through and see if the applicant meets the criteria presented by the company. Based on that a compatibility score is set. By default each criteria in the job post is equally weighted, but if some things are more important than others the recruiter can customize the algorithm to their needs to sort through the best candidates more quickly and effectively.
Social recruitment takes center stage
HCG: How does the job posting section on Businessfriend work and how can it help busy managers streamline the recruitment process?
PD:First of all, I think I should mention the first job post is free, because we believe before people pay for it they should know what they are paying for. We are very proud of it and believe we can afford to offer it for free because once a company uses it they will want to use it again. Businessfriend is built around communication and productivity tools. The Job Manager is no different.
In addition to the customized organization and automation, there are many other features that help streamline the process. The first one and most obvious one is the compatibility score. The recruiter can immediately go to the top candidates and sort through them first instead of wasting their time sorting through candidates who are not qualified for the position. Also each job post can have multiple admins. A Job Admin gets the full functionality of the Job Manager on their own personal profile. The tool is made for collaboration so their is a section on the Job Manager to pass notes back and forth, rate candidates, share new candidates with other admins, and create tags. All of this activity is visible to all admins, and is collected in an easy to read activity stream. We believe this really streamlines the communication between recruiters, and it collects all the information about the candidates in one place so the recruiter can stay organized and ultimately make the best recruitment decisions.
HCG: What other recruitment tools on Businessfriend could HR managers utelise in the healthcare sector?
PD:We are first and foremost a professional network so recruiters can browse users profile and look for new talent. We are growing quickly so recruiters can come back regularly and see new members signing up. In addition a recruiter can use our messaging platform to get in touch with possible recruits, the Doc Manager to be able to access important papers from any computer and any device, and the calendar to schedule their interviews and organize their schedule. Businessfriend is a flexible platform that is full of opportunity for any member that signs up.
Learn More About Businessfriend
The challenges to vaccine distribution affecting everyone
While it is comforting to know that vaccines against COVID-19 are showing remarkable efficacy, the world still faces intractable challenges with vaccine distribution. Specifically, the sheer number of vaccines required and the complexity of global supply chains are sure to present problems we have neither experienced nor even imagined.
Current projections estimate that we could need 12-15 billion doses of vaccine, but the largest vaccine manufacturers produce less than half this volume in a year. To understand the scale of the problem, imagine stacking one billion pennies – you would have a stack that is 950 miles high. Now, think of that times ten. This is a massive problem that one nation can’t solve alone.
Even if we have a vaccine – can we make enough? Based on current projections, Pfizer expects to produce up to 1.3 billion doses this year. Moderna is working to expand its capacity to one billion units this year. Serum Institute of India, the world’s largest vaccine producer, is likely to produce 60% of the 3 billion doses committed by AstraZeneca, Johnson & Johnson and Sanofi. This leaves us about 7 billion doses short.
Expanding vaccine production for most regions in the world is complicated and time-consuming. Unlike many traditional manufacturing operations that can expand relatively quickly and with limited regulation, pharmaceutical production must meet current good manufacturing practice (CGMP) guidelines. So, not only does it take time to transition from R&D to commercial manufacturing, but it could also take an additional six months to achieve CGMP certification.
The problem becomes even more complex when considering the co-products required. Glass vials and syringes are just two of the most essential co-products needed to produce a vaccine. Last year, before COVID-19, global demand for glass vials was 12 billion. Even if it is safe to dispense ten doses per vial, there is certain to be significant pressure on world supply of the materials needed to package and distribute a vaccine.
It is imperative drug manufacturers and their raw material suppliers have clear visibility of production plans and raw material availability if there is any hope of optimizing scarce resources and maximising production yield.
It is widely known by now that temperature is a critical factor for the COVID-19 vaccine. Even the regions with the most developed logistics infrastructures and resources needed to support a cold-chain network are sure to struggle with distribution.
For the United States alone, State and local health agencies have determined distribution costs will exceed $8.4 billion, including $3 billion for workforce recruitment and training; $1.2 billion for cold-chain, $1 billion vaccination sites and $0.5 billion IT upgrades.
The complexity of the problem increases further when considering countries such as India that do not have cold-chain logistics networks that meet vaccine requirements. Despite India’s network of 28,000 cold-chain units, none are capable of transporting vaccines below -25°Celsius. While India’s Serum Institute has licensed to manufacture AstraZeneca’s vaccine, which can reportedly be stored in standard refrigerated environments, even a regular vaccine cold chain poses major challenges.
Furthermore, security will undoubtedly become a significant concern that global authorities must address with a coordinated solution. According to the Pharmaceutical Security Institute, theft and counterfeiting of pharmaceutical products rose nearly 70% over the past five years. As with any valuable and scarce product, counterfeits will emerge. Suppliers and producers are actively working on innovative approaches to limit black-market interference. Corning, for example, is equipping vials with black-light verification to curb counterfeiting.
Clearly, this is a global problem that will require an unprecedented level of collaboration and coordination.
Disconnected information systems
While it is unreasonable to expect every country around the world will suddenly adopt a standard technology that would provide immediate, accurate and available information for everyone, it is not unreasonable to think that we can align on a standard taxonomy that can serve as a Rosetta Stone for collaboration.
A shared view of the situation (inventory, raw materials, delivery, defects) will provide every nation with the necessary information to make life-saving decisions, such as resource pooling, stock allocations and population coverage.
By allowing one central authority, such as the World Health Organization, to organize and align global leaders to a single collaboration standard, such as GS1, and a standard sharing protocol, such as DSCSA, then every supply chain participant will have the ability to predict, plan and execute in a way that maximises global health.
Political influence and social equality
As if we don’t have enough stress and churn in today’s geopolitical environment, we must now include the challenge of “vaccine nationalism.” While this might not appear to be a supply chain problem, per se, it is a critical challenge that will hinge on supply chain capabilities.
In response to the critical supply issues the world experienced with SARS-CoV-2, the World Health Organization, Gavi, the Vaccine Alliance and the Coalition for Epidemic Preparedness Innovations (CEPI) formed Covax: a coalition dedicated to equitable distribution of 2 billion doses of approved vaccines to its 172 member countries. Covax is currently facilitating a purchasing pool and has made commitments to buy massive quantities of approved vaccines when they become available.
However, several political powerhouse countries, such as the United States and Russia, are not participating. Instead, they are striking bilateral deals with drug manufacturers – essentially, competing with the rest of the world to secure a national supply. Allocating scarce resources is never easy, but when availability could mean the difference between life and death, it becomes almost impossible.
Global production, distribution and social equality present dependent yet conflicting realities that will demand global supply chains provide complete transparency and an immutable chain of custody imperative to vaccine distribution.
The technology is available today – we just need to use it. We have the ability to track every batch, pallet, box, vile and dose along the supply chain. We have the ability to know with absolute certainty that the vaccine is approved, where and when it was manufactured, how it was handled and whether it was compromised at any point in the supply chain. Modern blockchain technologies should be applied so that every nation, institution, regulator, doctor and patient can have confidence in knowing that they are making an impact in eradicating COVID-19.